CD14 and neoplasm: The recruitment [138] and polarization of CD14+ monocytes into the suppressive PD-L1+M2-like macrophages (co-expressing CD14 and/or CD163) by primary tumor cells (possibly via the secretion of CCL2) prevent the antigen presentation and immune response in the lymphatic niche [139].